Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [Tissue RNA-seq]

ABSTRACT: We sequenced 30 tissue samples from 15 colorectal cancer patients, including tumor and tumor-adjacent normal tissue (> 2cm from the primary tumor). These patients' plasma has been profiled.

ORGANISM(S): Homo sapiens

PROVIDER: GSE211831 | GEO | 2023/09/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [long RNA PBMC]

Project description:We sequenced 8 colorectal cancer patients' PBMC samples, and 6 healthy donors' PBMC samples. These individuals' plasma RNA have been profiled.

2023-09-28 | GSE218999 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-28 | GSE186607 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [miRNA-seq]

Project description:We sequenced cell-free nucleaic acid (cfNA) for 2 major cancer types (44 samples of colorectal cancer and 36 samples of stomach cancer) and 81 samples of healthy individuals collected in China. Cancer related signaling pathway were identified. Cancer detection and specific classification were achieved through combining both cfRNA and cfDNA reads.

2023-09-28 | GSE186595 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [long RNA]

2023-09-28 | GSE186587 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [MeDIP-seq]

2023-09-28 | GSE186575 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [DNA-seq]

2023-09-28 | GSE186573 | GEO

Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes

Project description:The aim of our study is to examine the region of tissue surrounding or adjacent to breast tumor in order to detect pre-malignant histological and genetic changes that may be predictive of risk of breast cancer. In this study, histological and gene expression data of breast tissue were obtained from patients that underwent mastectomy at various stages of breast carcinoma. For each patient, samples were obtained from the tumor region and four surrounding zones (1cm, 2cm, 3 cm and 4 cm away from the grossly visible tumor boundary), where possible. We have also breast samples from healthy individuals undergoing breast reduction surgery (mammoplasty). Microarray gene expression profiles of tissue samples (tumor and surrounding tissue, and breast reduction mammoplasty) was performed. In addition pathologist reviewed all slides to provide a details histology of all samples (excluding breast mammoplasty)

2008-04-13 | E-TABM-276 | biostudies-arrayexpress

Integrative omics analysis in HCC samples [lncRNA expression]

Project description:38 paires of tumor tissues and adjacent non-tumor tissues from HCC patients The number of known lncRNAs increased sharply upon the tiling microarrays and RNA-sequencing were applied to identify lncRNAs. However, only about a dozen of lncRNAs have been well characterized and demonstrated to be tightly associated with development and progression of HCC. A major challenge remains to identify functional lncRNAs associated with HCC. Previous reports mainly selected differentially expressed lncRNAs in cancer tissue or cell lines as candidates for further validation and characterizing. Here, based on mRNA and lncRNA gene expression profiles data collected from tumor and adjacent normal tissues of thirty-eight HCC patients, we adapted integrative omics strategy to identify HCC-associated lncRNAs.

2017-06-21 | GSE84004 | GEO

Integrative omics analysis in HCC samples [mRNA expression]

2017-06-21 | GSE84005 | GEO

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

Project description:HLA class I ligandome dataset obtained from hepatocellular carcinoma (HCC) as well as corresponding adjacent benign liver tissue (n=16) characterizing respective HLA immunoprecipitates. Additionally, from a subset of the mentioned HCC/ adjacent benign liver samples datasets gained from shotgun protein identification, comprising HCC as well as adjacent benign liver tissue (n=7) are provided. Further, for one patient shotgun protein identification was also performed in serum (blood) samples obtained after HCC recurrence.

2019-05-06 | PXD013057 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data